Early research (Phase 1)Ended earlyNCT05065463
What this trial is testing
To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.
Who this might be right for
End Stage Renal Disease
AstraZeneca 3